Insight Molecular Diagnostics Inc. (IMDX)
(Delayed Data from NSDQ)
$3.01 USD
-0.26 (-7.95%)
Updated Sep 23, 2025 04:00 PM ET
After-Market: $3.01 0.00 (0.00%) 5:40 PM ET
3-Hold of 5 3
F Value B Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Insight Molecular Diagnostics Inc. has a market cap of $93.59M, which represents its share price of $3.27 multiplied by its outstanding shares number of 28.62M. As a small-cap company, IMDX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IMDX 3.01 -0.26(-7.95%)
Will IMDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMDX
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
IMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for IMDX
NR7 appears for IMDX after 4.11% move
Pocket Pivot appears for IMDX after 1.19% move
Is IMDX primed for upward momentum? Upper Bollinger Band Walk shows up after gaining 1.81%
Insight Molecular Diagnostics Approves Executive Salary Increases
Is IMDX preparing to trend higher? New Uptrend shows up after slipping 3.78%